Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma
Clinical trial NCT05214222 · RECRUITING
Trial details
- NCT number
- NCT05214222
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2026-06-02
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.